1,2,3-Triazole-Dithiocarbamate Hybrids, a Group of Novel Cell Active SIRT1 Inhibitors
Yi‐Chao Zheng(Ministry of Education), Hong‐Min Liu(Kailuan General Hospital), Xue‐qi Liu(Hebei Medical University), Ying‐Chao Duan, Wen Zhao(Capital Medical University), Dandan Shen(Sir Run Run Shaw Hospital), Long-Zhen Wang(Ministry of Education of the People's Republic of China), Zhe‐Sheng Chen(New York College of Traditional Chinese Medicine), Qian-Na Zhan(Ministry of Education of the People's Republic of China), Zhi-Ru Wang(Zhengzhou University), Bin Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Liu(Brown Foundation), Jinfeng Li(Hebei Medical University), Mengmeng Wang(Ministry of Education of the People's Republic of China), Lijuan Zhao(Ministry of Education of the People's Republic of China), Wen-Lei Lv(Zhengzhou University), Jinlian Ma(Wenzhou Medical University), Meng Ren(Sun Yat-sen University)
Cited by 9
Related Papers
Microbiota in health and diseases
|Signal Transduction and Targeted Therapy|2022|2.9k
Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
|Cell Death and Differentiation|2019|582
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
|Cancer Research|2008|385
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens
|Frontiers in Pharmacology|2021|271